The Hydration Pharmaceuticals CoASX:HPC Return-on-Tangible-Equity is -238.33% as of Dec. 2025. The stock has 3 warning signs investors should review. Among 298 Retail - Defensive companies, The Hydration Pharmaceuticals Co ranks worse than 98.32% on this metric.
The historical rank and industry rank for The Hydration Pharmaceuticals Co's Return-on-Tangible-Equity or its related term are showing as below:
ASX:HPC'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -451.22 Med: -133.19 Max: 222.03
Current: -141.64
During the past 5 years, The Hydration Pharmaceuticals Co's highest Return-on-Tangible-Equity was 222.03%. The lowest was -451.22%. And the median was -133.19%.
ASX:HPC's Return-on-Tangible-Equity is ranked worse than 98.32% of 298
companies
in the Retail - Defensive industry
Industry Median: 11.085
vs ASX:HPC: -141.64
The Hydration Pharmaceuticals Co (ASX:HPC) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
The Hydration Pharmaceuticals Co Return-on-Tangible-Equity Related Terms
The Hydration Pharmaceuticals Co Return-on-Tangible-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Hydration Pharmaceuticals Co Return-on-Tangible-Equity Chart
ASX:HPC vs SYY, USFD, PFGC: Return-on-Tangible-Equity Comparison
For the Food Distribution subindustry, The Hydration Pharmaceuticals Co's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Hydration Pharmaceuticals Co Return-on-Tangible-Equity vs Retail - Defensive Industry
For the Retail - Defensive industry and Consumer Defensive sector, The Hydration Pharmaceuticals Co's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where The Hydration Pharmaceuticals Co's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Dec. 2025) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of -238.33% mean?
The Hydration Pharmaceuticals Co (ASX:HPC) has a Return-on-Tangible-Equity of -238.33% as of Dec. 2025. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on The Hydration Pharmaceuticals Co and its competitors. According to the industry distribution chart, The Hydration Pharmaceuticals Co ranks #293 out of 298 companies in the Retail - Defensive industry, placing it in the top 98.3%.
Is The Hydration Pharmaceuticals Co's Return-on-Tangible-Equity too high?
The Hydration Pharmaceuticals Co's current Return-on-Tangible-Equity is -238.33%. Based on the distribution chart, The Hydration Pharmaceuticals Co ranks #293 out of 298 companies in the Retail - Defensive industry, which is in the bottom quartile relative to peers.
How does The Hydration Pharmaceuticals Co's Return-on-Tangible-Equity compare to SYY and USFD?
According to the Retail - Defensive industry distribution chart, The Hydration Pharmaceuticals Co ranks #293 out of 298 companies for Return-on-Tangible-Equity. This places The Hydration Pharmaceuticals Co in the lower half of its industry. The industry median Return-on-Tangible-Equity is 11.09. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Retail - Defensive company?
The median Return-on-Tangible-Equity among Retail - Defensive companies is 11.09, based on 298 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on The Hydration Pharmaceuticals Co and its competitors. For the Retail - Defensive industry, the median Return-on-Tangible-Equity is 11.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The Hydration Pharmaceuticals Co's current Return-on-Tangible-Equity is -238.33%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Hydration Pharmaceuticals Co stock overvalued right now?
The Hydration Pharmaceuticals Co (ASX:HPC) has a current Return-on-Tangible-Equity of -238.33%. The current Return-on-Tangible-Equity is -238.33%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For The Hydration Pharmaceuticals Co (ASX:HPC), the current Return-on-Tangible-Equity is -238.33% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
The Hydration Pharmaceuticals Co Business Description
The Hydration Pharmaceuticals Co Ltd is a consumer products company that markets and sells a range of liquid, tablet and powder Healthy Hydration Solutions products into the USA market, under the Hydralyte brand. Hydralyte collates and translates consumer insights and needs into developing and delivering quality hydration products to market. The Company's business model is an asset light, flexible production model that allows it to outsource manufacturing and packaging to appropriate suppliers.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:HPC has been successfully added to your 